OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 02, 2012
Experts discuss solutions for filter bacterial retention and related challenges. Contains online bonus material.
January 19, 2012
The generic-drugs market is poised to experience strong growth as key blockbuster products go off patent, but companies looking to benefit from this will have to be careful about the product segments where they compete, according to a report from Frost & Sullivan.
January 12, 2012
The pharmaceutical majors advance vaccines for the developing world.
January 02, 2012
The authors designed an upper punch with a removable punch tip to determine a tablet formulation's propensity to stick by weighing the mass of powder adhered to the punch tip.
Challenges remain, particularly for early-stage biopharmaceutical companies.
Technology may expedite operations, but the absence of the human element could cost dearly.
Industry experts discuss formulation and technical challenges in multilayer tablet manufacture.
January 01, 2012
Multilayer tablets can be challenging, but meeting regulatory expectations is crucial. We speak with Vilayat Sayeed from the FDA, to find out more about the critical factors that need to be fully understood.
December 29, 2011
Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries. Pneumococcal disease can lead to pneumonia, meningitis, and sepsis, and is one of leading causes of death in children under the age of five in developing countries.
AstraZeneca Acquires Chinese Generic-Drug Company; Takeda Makes Management Changes; and More.